These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10194091)

  • 21. Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration.
    Jirathitikal V; Metadilogkul O; Bourinbaiar AS
    Eur J Clin Nutr; 2004 Jan; 58(1):110-5. PubMed ID: 14679375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
    Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
    Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
    Sardar P; Jha A; Roy D; Majumdar U; Guha P; Roy S; Banerjee R; Banerjee AK; Bandyopadhyay D
    HIV Clin Trials; 2010; 11(4):220-9. PubMed ID: 20974577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
    Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
    Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen therapy in AIDS wasting.
    Dobs AS
    Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):379-90. PubMed ID: 10332560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
    Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
    Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone release rate and duration of action of testosterone pellet implants.
    Kelleher S; Howe C; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss.
    Montano M; Flanagan JN; Jiang L; Sebastiani P; Rarick M; LeBrasseur NK; Morris CA; Jasuja R; Bhasin S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2793-802. PubMed ID: 17440010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study.
    Dolan S; Wilkie S; Aliabadi N; Sullivan MP; Basgoz N; Davis B; Grinspoon S
    Arch Intern Med; 2004 Apr; 164(8):897-904. PubMed ID: 15111377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy.
    Orengo CA; Fullerton L; Kunik ME
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):20-4. PubMed ID: 15681624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
    Hengge UR; Stocks K; Wiehler H; Faulkner S; Esser S; Lorenz C; Jentzen W; Hengge D; Goos M; Dudley RE; Ringham G
    AIDS; 2003 Mar; 17(5):699-710. PubMed ID: 12646793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?
    Bhasin S; Javanbakht M
    JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S195-201. PubMed ID: 10571455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR; Stocks K; Faulkner S; Wiehler H; Lorenz C; Jentzen W; Hengge D; Ringham G
    HIV Clin Trials; 2003; 4(3):150-63. PubMed ID: 12815555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
    Grinspoon S; Corcoran C; Parlman K; Costello M; Rosenthal D; Anderson E; Stanley T; Schoenfeld D; Burrows B; Hayden D; Basgoz N; Klibanski A
    Ann Intern Med; 2000 Sep; 133(5):348-55. PubMed ID: 10979879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
    Schambelan M; Mulligan K; Grunfeld C; Daar ES; LaMarca A; Kotler DP; Wang J; Bozzette SA; Breitmeyer JB
    Ann Intern Med; 1996 Dec; 125(11):873-82. PubMed ID: 8967667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.